These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32162079)

  • 21. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
    He B; Lin X; Tian F; Yu W; Qiao B
    J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
    Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
    Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of SRSF3 is Correlated with Carcinogenesis and Progression of Oral Squamous Cell Carcinoma.
    Peiqi L; Zhaozhong G; Yaotian Y; Jun J; Jihua G; Rong J
    Int J Med Sci; 2016; 13(7):533-9. PubMed ID: 27429590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction.
    Polachini GM; de Castro TB; Smarra LFS; Henrique T; de Paula CHD; Severino P; López RVM; Carvalho AL; de Mattos Zeri AC; Silva IDCG; Tajara EH
    Sci Rep; 2023 May; 13(1):8588. PubMed ID: 37237049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
    Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
    Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated Lin28B expression is correlated with lymph node metastasis in oral squamous cell carcinomas.
    Lin WT; Shieh TM; Yang LC; Wang TY; Chou MY; Yu CC
    J Oral Pathol Med; 2015 Nov; 44(10):823-30. PubMed ID: 25726847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
    BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Resolution Magic Angle Spinning (HRMAS) NMR Methods in Metabolomics.
    Tilgner M; Vater TS; Habbel P; Cheng LL
    Methods Mol Biol; 2019; 2037():49-67. PubMed ID: 31463839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer.
    Xiong H; Yang Y; Yang K; Zhao D; Tang H; Ran X
    Int J Oncol; 2018 Jan; 52(1):279-287. PubMed ID: 29115399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and potential clinical significance of cytidine triphosphate: phosphocholine cytidylyltransferase-α in oral squamous cell carcinoma].
    Lu FC; Xie XY; Yin XM; Gao YJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):254-258. PubMed ID: 29690696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.